Ryan Brinkman

Stock Analyst at JP Morgan

(2.46)
# 2,358
Out of 5,182 analysts
283
Total ratings
50.51%
Success rate
-2.88%
Average return

Stocks Rated by Ryan Brinkman

Visteon
Mar 9, 2026
Maintains: Neutral
Price Target: $118$110
Current: $93.43
Upside: +17.74%
BorgWarner
Feb 12, 2026
Maintains: Overweight
Price Target: $56$76
Current: $53.56
Upside: +41.90%
Adient
Feb 6, 2026
Maintains: Neutral
Price Target: $24$28
Current: $20.66
Upside: +35.53%
General Motors Company
Jan 21, 2026
Maintains: Overweight
Price Target: $85$100
Current: $76.83
Upside: +30.16%
Ford Motor Company
Jan 21, 2026
Maintains: Overweight
Price Target: $14$15
Current: $12.16
Upside: +23.36%
Garrett Motion
Dec 17, 2025
Initiates: Overweight
Price Target: $23
Current: $19.35
Upside: +18.86%
Ferrari
Nov 12, 2025
Maintains: Overweight
Price Target: $460$457
Current: $355.14
Upside: +28.68%
Camping World Holdings
Nov 3, 2025
Maintains: Overweight
Price Target: $22$19
Current: $7.08
Upside: +168.36%
Lear Corporation
Nov 3, 2025
Maintains: Overweight
Price Target: $133$138
Current: $123.22
Upside: +11.99%
Dana Incorporated
Nov 3, 2025
Maintains: Overweight
Price Target: $26$28
Current: $36.69
Upside: -23.68%
Maintains: Overweight
Price Target: $15$14
Current: $7.03
Upside: +99.15%
Maintains: Underweight
Price Target: $9$10
Current: $15.90
Upside: -37.11%
Maintains: Neutral
Price Target: $155$157
Current: $371.01
Upside: -57.68%
Maintains: Overweight
Price Target: $48$53
Current: $58.26
Upside: -9.03%
Maintains: Neutral
Price Target: $38$43
Current: $29.42
Upside: +46.16%
Maintains: Neutral
Price Target: $30$32
Current: $22.13
Upside: +44.60%
Maintains: Overweight
Price Target: $90$105
Current: $59.36
Upside: +76.89%
Maintains: Underweight
Price Target: $120$115
Current: $352.42
Upside: -67.37%
Downgrades: Underweight
Price Target: n/a
Current: $6.61
Upside: -
Maintains: Neutral
Price Target: $117$129
Current: $110.38
Upside: +16.87%
Reinstates: Overweight
Price Target: $20
Current: $39.50
Upside: -49.37%
Upgrades: Neutral
Price Target: $16
Current: $33.25
Upside: -51.13%